Cargando…

Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study

The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experience with brolucizumab in wet AMD) was a retrospective, observational, multice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilgic, Alper, Kodjikian, Laurent, March de Ribot, Francesc, Vasavada, Vaishali, Gonzalez-Cortes, Jesus H., Abukashabah, Amro, Sudhalkar, Aditya, Mathis, Thibaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268719/ https://www.ncbi.nlm.nih.gov/pubmed/34201729 http://dx.doi.org/10.3390/jcm10132758

Ejemplares similares

Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study
por: Bilgic, Alper, et al.
Publicado: (2021)

Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid
por: Bilgic, Alper, et al.
Publicado: (2021)

Current intravitreal therapy and ocular hypertension: A review
por: Sudhalkar, Aditya, et al.
Publicado: (2021)

Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema
por: Gonzalez-Cortes, Jesus H., et al.
Publicado: (2022)

Retinal Vascularization Analysis on Optical Coherence Tomography Angiography before and after Intraretinal or Subretinal Fluid Resorption in Exudative Age-Related Macular Degeneration: A Pilot Study
por: Mathis, Thibaud, et al.
Publicado: (2021)

Risk Factors for COVID-19 Associated Mucormycosis: The Ophthalmologist’s Perspective
por: Bilgic, Alper, et al.
Publicado: (2022)

Relevance of Visual Acuity Measurement for Therapeutic Decisions in Diabetic Macular Edema
por: Mathis, Thibaud, et al.
Publicado: (2023)

Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
por: Bilgic, Alper, et al.
Publicado: (2020)

Brolucizumab for macular degeneration
Publicado: (2020)

Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
por: Bilgic, Alper, et al.
Publicado: (2020)

Impact of fluidic parameters during phacoemulsification on the anterior vitreous face behavior: Experimental study
por: Vasavada, Vaishali, et al.
Publicado: (2019)

Age-Related Macular Degeneration: New Insights in Diagnosis, Treatment, and Prevention
por: Mathis, Thibaud, et al.
Publicado: (2022)

Cortical aspiration - The “POPS” technique
por: Vasavada, Viraj A, et al.
Publicado: (2020)

Three-Month Results of Brolucizumab Intravitreal Therapy in Patients with Wet Age-Related Macular Degeneration
por: Michalska-Małecka, Katarzyna, et al.
Publicado: (2021)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
por: Avaylon, Jaycob, et al.
Publicado: (2020)

Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients
por: Gesualdo, Carlo, et al.
Publicado: (2023)

Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study
por: Mathis, Thibaud, et al.
Publicado: (2022)

Bilateral blindness after uneventful brolucizumab injection for macular degeneration
por: Barchichat, Ilan, et al.
Publicado: (2022)

Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)
por: Van Cleemput, Liesbeth, et al.
Publicado: (2023)

Minimal surgery for tractional retinal detachment secondary to branch retinal vein occlusion: a case report
por: Bilgic, Alper, et al.
Publicado: (2022)

Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
por: Yannuzzi, Nicolas A, et al.
Publicado: (2019)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
por: Musiał-Kopiejka, Magdalena, et al.
Publicado: (2022)

Acute full-thickness macular hole after uneventful femtosecond-assisted cataract surgery and its spontaneous closure
por: Bhojwani, Deepak, et al.
Publicado: (2018)

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
por: Maggio, Emilia, et al.
Publicado: (2022)

Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
por: Garweg, Justus G., et al.
Publicado: (2023)

Relevance of Visual Acuity Measurement for Therapeutic Decisions in Age-Related Macular Degeneration
por: Mathis, Thibaud, et al.
Publicado: (2023)

The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
por: Bae, Ki Woong, et al.
Publicado: (2022)

Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies
por: Kodjikian, Laurent, et al.
Publicado: (2018)

Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy
por: Hsu, Alan Y., et al.
Publicado: (2022)

Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments
por: Hussain, Rehan M., et al.
Publicado: (2021)

Decoding fluid droplet generation during phacoemulsification and pars plana procedures in the COVID-19 era—An experimental study
por: Srivastava, Samaresh, et al.
Publicado: (2020)

Spontaneous closure of an idiopathic macular hole after epiretinal membrane development
por: Gonzalez-Cortes, Jesus Hernan, et al.
Publicado: (2022)

An Overview of REBA Method Applications in the World
por: Hita-Gutiérrez, Manuel, et al.
Publicado: (2020)

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
por: Chakraborty, Debdulal, et al.
Publicado: (2021)

Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study
por: Pinto, Mauricio, et al.
Publicado: (2021)

Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration
por: Mukai, Ryo, et al.
Publicado: (2021)

Biomarkers in Early Response to Brolucizumab on Pigment Epithelium Detachment Associated with Exudative Age-Related Macular Degeneration
por: Rispoli, Marco, et al.
Publicado: (2021)

Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis
por: Hänsli, Christof, et al.
Publicado: (2023)

Brolucizumab vs aflibercept and ranibizumab for neovascular age-related macular degeneration: a cost-effectiveness analysis
por: Yu, Justin S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ah7dq95e7ccqsuqq3m1p48ihnu